Alzamend Neuro has partnered with Massachusetts General Hospital to conduct a pioneering Phase II clinical trial of its AL001 treatment for PTSD, led by Dr. Ovidiu Andronesi.
Tag: ALZN
Bitcoin(BTC)$97,974.103.86%
Ethereum(ETH)$3,351.739.04%
Tether USDt(USDT)$1.000.03%
Solana(SOL)$254.508.19%
BNB(BNB)$622.292.08%
XRP(XRP)$1.187.85%
Dogecoin(DOGE)$0.3869912.50%
USDC(USDC)$1.000.02%
Cardano(ADA)$0.79-1.71%
TRON(TRX)$0.1989691.68%